NTLA R&D Expenses
Intellia Therapeutics Inc · R&D Expenses
NTLA R&D Expenses
Latest reported$82.60Mperiod ending
NTLA Quarterly R&D Expenses ($11.00K → $82.60M)
Quarterly R&D Expenses
High-resolution chart · PNG
NTLA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 82,595,000 | |
| 80,737,000 | |
| 88,652,000 | |
| 94,747,000 | |
| 97,035,000 | |
| 108,427,000 | |
| 116,877,000 | |
| 123,380,000 | |
| 111,608,000 | |
| 109,335,000 | |
| 108,981,000 | |
| 113,696,000 | |
| 115,276,000 | |
| 97,116,000 | |
| 100,034,000 | |
| 96,651,000 | |
| 90,199,000 | |
| 133,095,000 | |
| 71,161,000 | |
| 60,486,000 | |
| 58,884,000 | |
| 39,276,000 | |
| 38,231,000 | |
| 39,756,000 | |
| 37,771,000 | |
| 34,650,000 | |
| 31,731,000 | |
| 27,513,000 | |
| 25,460,000 | |
| 23,709,000 | |
| 19,918,000 | |
| 23,237,000 | |
| 23,467,000 | |
| 22,493,000 | |
| 21,170,000 | |
| 17,481,000 | |
| 15,565,000 | |
| 13,431,000 | |
| 11,331,000 | |
| 7,861,000 | |
| 7,423,000 | |
| 5,225,000 | |
| 4,375,000 | |
| 3,458,000 | |
| 1,966,000 | |
| 1,371,000 | |
| 4,502,000 | |
| 11,000 |